Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=29026937

A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin

Author
BRANA, Irene1 ; OCANA, Alberto1 ; BEDARD, Philippe L1 ; CHEN, Eric X1 ; RAZAK, Albiruni R. A1 ; HAINES, Christine1 ; LEE, Carol2 ; DOUGLAS, Sarah1 ; WANG, Lisa1 ; SIU, Lillian L1 ; TANNOCK, Ian F1
[1] Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, 610 University Avenue, M5G 2 M9 Toronto, ON, Canada
[2] Departments of Medical Biophysics and Medical Oncology and Hematology, Princess Margaret Hospital/Ontario Cancer Institute, University of Toronto, 610 University Avenue, Toronto, ON M5G 2 M9, Canada
Source

Investigational new drugs. 2014, Vol 32, Num 6, pp 1269-1277, 9 p ; ref : 38 ref

CODEN
INNDDK
ISSN
0167-6997
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Springer, New York, NY
Publication country
United States
Document type
Article
Language
English
Author keyword
Autophagy Doxorubicin Drug distribution Pantoprazole
Keyword (fr)
Anticancéreux Association médicamenteuse Autophagie Distribution Doxorubicine Essai clinique phase I Evaluation Homme Médicament Pantoprazole Pharmacocinétique Pénétration Stade avancé Toxicité Tumeur solide Anthracyclines Cancer DNA topoisomerase (ATP-hydrolysing) Dérivé du benzimidazole Enzyme H+/K+-exchanging ATPase Hydrolases Inhibiteur de la topoisomérase II Inhibiteur enzyme Inhibiteur pompe proton Isomerases Tumeur maligne
Keyword (en)
Antineoplastic agent Drug combination Autophagy Distribution Doxorubicin Phase I trial Evaluation Human Drug Pantoprazole Pharmacokinetics Penetration Advanced stage Toxicity Solid tumor Anthracyclins Cancer DNA topoisomerase (ATP-hydrolysing) Benzimidazole derivatives Enzyme H+/K+-exchanging ATPase Hydrolases Topoisomerase II inhibitor Enzyme inhibitor Proton pump inhibitor Isomerases Malignant tumor
Keyword (es)
Anticanceroso Asociación medicamentosa Autofagia Distribución Doxorubicina Ensayo clínico fase I Evaluación Hombre Medicamento Pantoprazol Farmacocinética Penetración Estadio avanzado Toxicidad Tumor sólido Antraciclinas Cáncer DNA topoisomerase (ATP-hydrolysing) Benzimidazol derivado Enzima H+/K+-exchanging ATPase Hydrolases Inhibidor topoisomerase II Inhibidor enzima Inhibidor bomba protón Isomerases Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)

Discipline
Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
29026937

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web